All Articles

A South Korean lab has cracked a key battery problem, promising safer, ultra-fast EV charging. But can this new anode design outpace global rivals?

Curium's landmark $8 billion acquisition of Lantheus is set to create a global powerhouse in nuclear medicine, reshaping patient care and the competitive landscape.

Enterprise AI leader Yellow.ai is going public via a SPAC merger, aiming to deploy autonomous agents and disrupt the massive $900 billion BPO industry.

A new defense tech player just landed a major Air Force deal. We go beyond the headlines to reveal the financial machinery and strategic plays driving it.

As Students 2 Science founder Dr. Paul Winslow steps back, the nonprofit signals a new growth phase by promoting a proven leader from within its own ranks.

Autolus Therapeutics reports a 100% year-over-year sales jump and a stunning gross margin reversal, securing a $250M credit facility to fund its next big move.

Biocon's Yesafili, an interchangeable biosimilar to the $5.9B eye drug Eylea, launches in the US, promising major cost savings and market disruption.

The German prosthetics giant just built its first US facility from scratch. It’s more than a clinic; it's a bet on transparency, community, and the 2028 Paralympics.

As AI models multiply, 'subscription fatigue' is overwhelming users. A new service, Ask-Chat.ai, bundles 20+ top AIs, signaling a market shift toward aggregation.

Lipocine's appointment of M&A veteran Michael Grissinger isn't just a new face on the board; it's a clear signal of a strategic pivot towards high-stakes partnerships.

Beyond its star-studded Seattle gala, the Asian Hall of Fame is pioneering a new philanthropic model focused on neurodiversity, women in tech, and legacy.

Fresh off a $260M IPO, Seaport Therapeutics is advancing a de-risked pipeline for depression and anxiety, leveraging its novel platform to unlock new potential.

Robinson Helicopter's new 10-seat R88 debuts in Brazil, targeting a critical gap in the market. Is this the cost-effective workhorse the region needs?

Zac Brown Band's cruise giveaway is more than a thank you; it's a blueprint for deep brand integration and a new, high-stakes era of fan engagement.

ADAMA's appointment of a top M&A lawyer as General Counsel reveals a strategy focused on global growth, innovation, and navigating a complex ag-tech landscape.

With blockbuster sales for its MS drug BRIUMVI, TG Therapeutics is raising revenue targets and aggressively expanding its pipeline into new diseases.

The healthcare network appoints Jonathan Coggins to scale operations and Mandy Lawrence to a new CXO role, a dual strategy to accelerate growth and redefine care.

Riding a wave of strong Q2 results, Supernus announces a merger of equals with Indivior, set to create a new, scaled player in CNS and addiction medicine.

Private equity giant KKR is acquiring medical device maker Integer in a $5.7B deal, signaling a major investment in the future of outsourced MedTech innovation.

With its second major acquisition of 2026, COEO Solutions is building an IT services giant for the underserved mid-market. What does this mean for the future?